Search results
Results From The WOW.Com Content Network
If worldwide action is not taken to combat antibiotic misuse and the development of antimicrobial resistance, from 2014 – 2050 it is estimated that 300 million people could die prematurely due to drug resistance and $60 – 100 trillion of economic output would be lost. [24]
According to the Centers for Disease Control and Prevention, overuse and misuse of antibiotics have already created a slew of antibiotic-resistant bugs that cost the country upwards of $20 billion ...
Overuse of antibiotics and other antimicrobial drugs during the coronavirus pandemic is helping bacteria develop resistance that will render these important medicines ineffective over time, the ...
A review of investigational antibiotics shows that several new agents will become available in the coming years, even though the pace of antimicrobial research has proven far too slow. Overuse of antimicrobial agents and problems with infection control practices have led to the development of multidrug-resistant gram-negative bacterial infections.
Unnecessary health care (overutilization, overuse, or overtreatment) is health care provided with a higher volume or cost than is appropriate. [1] In the United States, where health care costs are the highest as a percentage of GDP, overuse was the predominant factor in its expense, accounting for about a third of its health care spending ($750 billion out of $2.6 trillion) in 2012.
Worldwide, antimicrobial resistance killed at least 1.27 million people in 2019. Overuse and misuse of antibiotics by people and animals and the effects of the pandemic have worsened the crisis ...
Common forms of antibiotic misuse include excessive use of prophylactic antibiotics in travelers and failure of medical professionals to prescribe the correct dosage of antibiotics on the basis of the patient's weight and history of prior use. Other forms of misuse include failure to take the entire prescribed course of the antibiotic ...
In some cases, antibiotic resistance is spreading to Gram-negative bacteria that can infect people outside the hospital. "For gram-positives we need better drugs; for gram-negatives we need any drugs", said Brad Spellberg, an infectious-disease specialist at Harbor–UCLA Medical Center , and the author of Rising Plague , a book about drug ...